Company Page

COMPASS Pathways

COMPASS Pathways is a pioneering entity in the realm of mental health, committed to devising innovative therapies to alleviate mental health challenges. Through its robust therapist training program, designed by a cadre of experts from psychology, psychiatry, and psychedelic therapy research domains, COMPASS prepares therapists for clinical studies involving COMP360 psilocybin treatment. This training is rigorous and well-rounded, beginning with 10 hours of theoretical online learning, followed by three days of in-person practical skills training, and culminating in clinical training through both live and recorded cases. The program also offers continuous professional development through mentoring, ensuring therapists are well-equipped to foster genuine, trusting, and safe therapeutic relationships.

The essence of COMPASS Pathways extends beyond training to a larger vision of a world imbued with mental wellbeing. Their inaugural venture is the global phase 3 program developing the investigational COMP360 treatment for individuals grappling with treatment-resistant depression. This initiative, along with their ongoing commitment to enhancing the therapist training model based on evidence-driven results for optimal patient experiences and outcomes, underscores COMPASS's earnest endeavor to transform the mental health landscape. Through these efforts, COMPASS Pathways is not only advancing psychedelic education but also creating a ripple of positive change in mental healthcare.

• Teaches: Globally
• Website: https://compasspathways.com/our-work/therapist-training/